Data / Form D filings / Lacerta Therapeutics, Inc.
Lacerta Therapeutics, Inc.: Form D filings
Lacerta Therapeutics, Inc., a biotechnology company in Alachua, FL, filed 2 Form D notices with the SEC in 2018. The latest, on August 7, 2018, reports an offering of $30 million with nothing sold yet.
Find out what Lacerta Therapeutics, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 12085 RESEARCH DRIVE, SUITE 46, Alachua, FL, 32615
- Phone
- (352) 514-7669
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2017
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1748465
The full lists. Form D filings in Florida: 2,702 rows, $107.02, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 7, 2018 | New notice | $30,000,000 | $0 | $30,000,000 | 0 | Yet to occur | sec.gov |
| Aug 7, 2018 | New notice | $500,000 | $500,000 | $0 | 6 | Jun 27, 2017 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| James D. Rusche | Director | |
| Nicholas D. Muzyczka | Director | |
| Joseph D. Reddy | Executive Officer, Director, Promoter | |
| Barry D. Byrne | Director, Promoter | |
| Kenneth D. Warrington | Executive Officer, Promoter | |
| Sergei D. Zolotukhin | Director, Promoter |
Other biotechnology companies in Florida that filed recently
- AdhereBio LLC offering · Oct 26, 2026
- Ascoltare Holdings LLC $1.7 million · Oct 23, 2026
- Immorta Bio, Inc. $612,503 · Oct 16, 2026
- CURADEL SURGICAL INNOVATIONS, INC. $49.8 million · Oct 13, 2026
- BioStem Technologies, Inc. $3 million · Oct 9, 2026
- HCW Biologics Inc. $1.5 million · Oct 8, 2026
- RHEOS MEDICAL CORP. $387,773 · Oct 7, 2026
- DIGITAL ETHER COMPUTING, LLC $625,000 · Sep 23, 2026
- Jupiter Biomedical Research, Inc. $30,000 · Sep 21, 2026
- Kaida BioPharma Inc. $1.6 million · Sep 1, 2026
- StrataBio Inc. $25,000 · Aug 31, 2026
- LUREX BIO, INC $150,000 · Aug 31, 2026
- EXUMA Biotech Corp. $70 million · Aug 20, 2026
- CRESCEL LLC $1.1 million · Aug 19, 2026
- EnduraFAST Inc. $50,000 · Aug 17, 2026
Every Form D from the week of Aug 6, 2018 · All recent filings in Florida · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Lacerta Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.